Search Results - "KAWUT, S. M"

Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study by BARR, R. G, ARMED, F. S, CARR, J. J, HOFFMAN, E. A, JIANG, R, KAWUT, S. M, WATSON, K

“…Airflow obstruction is an independent risk factor for cardiovascular events in the general population. The affected vascular bed and contribution of emphysema…”
Get full text

Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis by HOOK, J. L, ARCASOY, S. M, ZEMMEL, D, BARTERS, M. N, KAWUT, S. M, LEDERER, D. J

“…The supplemental oxygen flow rate is a common bedside measure of gas exchange impairment. We aimed to determine whether a titrated oxygen requirement (TOR)…”
Get full text

Early Plasma Soluble Receptor for Advanced Glycation End‐Product Levels Are Associated With Bronchiolitis Obliterans Syndrome by Shah, R. J., Bellamy, S. L., Lee, J. C., Cantu, E., Diamond, J. M., Mangalmurti, N., Kawut, S. M., Ware, L. B., Christie, J. D.

“…Early epithelial injury after lung transplantation may contribute to development of bronchiolitis obliterans syndrome (BOS). We evaluated the relationship…”
Get full text

Elevated Plasma Long Pentraxin‐3 Levels and Primary Graft Dysfunction After Lung Transplantation for Idiopathic Pulmonary Fibrosis by Diamond, J. M., Lederer, D. J., Kawut, S. M., Lee, J., Ahya, V. N., Bellamy, S., Palmer, S. M., Lama, V. N., Bhorade, S., Crespo, M., Demissie, E., Sonett, J., Wille, K., Orens, J., Shah, P. D., Weinacker, A., Weill, D., Kohl, B. A., Deutschman, C. C., Arcasoy, S., Shah, A. S., Belperio, J. A., Wilkes, D., Reynolds, J. M., Ware, L. B., Christie, J. D.

“…Primary graft dysfunction (PGD) after lung transplantation may result from ischemia reperfusion injury (IRI). The innate immune response to IRI may be mediated…”
Get full text

Preoperative Plasma Club (Clara) Cell Secretory Protein Levels Are Associated With Primary Graft Dysfunction After Lung Transplantation by Shah, R. J., Wickersham, N., Lederer, D. J., Palmer, S. M., Cantu, E., Diamond, J. M., Kawut, S. M., Lama, V. N., Bhorade, S., Crespo, M., Demissie, E., Sonett, J., Wille, K., Orens, J., Weinacker, A., Shah, P., Arcasoy, S., Wilkes, D. S., Christie, J. D., Ware, L. B.

“…Inherent recipient factors, including pretransplant diagnosis, obesity and elevated pulmonary pressures, are established primary graft dysfunction (PGD) risks…”
Get full text

Plasma Intercellular Adhesion Molecule‐1 and von Willebrand Factor in Primary Graft Dysfunction After Lung Transplantation by Covarrubias, M., Ware, L. B., Kawut, S. M., De Andrade, J., Milstone, A., Weinacker, A., Orens, J., Lama, V., Wille, K., Bellamy, S., Shah, C., Demissie, E., Christie, J. D.

“…Primary graft dysfunction (PGD), a form of acute lung injury occurring within 72 h following lung transplantation, is characterized by pulmonary edema and…”
Get full text

Elevated Plasma Clara Cell Secretory Protein Concentration Is Associated with High‐Grade Primary Graft Dysfunction by Diamond, J. M., Kawut, S. M., Lederer, D. J., Ahya, V. N., Kohl, B., Sonett, J., Palmer, S. M., Crespo, M., Wille, K., Lama, V. N., Shah, P. D., Orens, J., Bhorade, S., Weinacker, A., Demissie, E., Bellamy, S., Christie, J. D., Ware, L. B.

“…Primary graft dysfunction (PGD) is the leading cause of early posttransplant morbidity and mortality after lung transplantation. Clara cell secretory protein…”
Get full text

Racial and Ethnic Disparities in Idiopathic Pulmonary Fibrosis: A UNOS/OPTN Database Analysis by Lederer, D. J., Arcasoy, S. M., Barr, R. G., Wilt, J. S., Bagiella, E., D'Ovidio, F., Sonett, J. R., Kawut, S. M.

“…We previously reported poorer survival among non‐Hispanic blacks and Hispanics with idiopathic pulmonary fibrosis (IPF) compared to non‐Hispanic whites at our…”
Get full text

Racial and Ethnic Disparities in Survival in Lung Transplant Candidates with Idiopathic Pulmonary Fibrosis by Lederer, D. J., Caplan‐Shaw, C. E., O'Shea, M. K., Wilt, J. S., Basner, R. C., Bartels, M. N., Sonett, J. R., Arcasoy, S. M., Kawut, S. M.

“…Minority patients have worse outcomes than nonminority patients in a variety of pulmonary diseases. We aimed to compare the survival of Black and Hispanic…”
Get full text

A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension by Robbins, I. M, Kawut, S. M, Yung, D, Reilly, M. P, Lloyd, W, Cunningham, G, Loscalzo, J, Kimmel, S. E, Christman, B. W, Barst, R. J

“…Idiopathic pulmonary arterial hypertension (IPAH) is characterised by in situ thrombosis and increased thromboxane (Tx) A2 synthesis; however, there are no…”
Get full text

Plasma Cytokines and Chemokines in Primary Graft Dysfunction Post-Lung Transplantation by HOFLMAN, S. A, WANG, L, WARE, L. B, ORENS, J, WEINACKER, A, DEMISSIE, E, BELLAMY, S, KAWUT, S. M, HANCOCK, W. W, CHRISTIE, J. D, SHAH, C. V, AHYA, V. N, POCHETTINO, A, OLTHOFL, K, SHAKED, A, WILLE, K, LAMA, V. N, MILSTONE, A

Get full text

MELD Exceptions for Portopulmonary Hypertension: Current Policy and Future Implementation by Goldberg, D. S., Batra, S., Sahay, S., Kawut, S. M., Fallon, M. B.

“…Since 2006, waitlist candidates with portopulmonary hypertension (POPH) have been eligible for standardized Model for End‐Stage Liver Disease (MELD) exception…”
Get full text

Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation by Shah, R. J., Diamond, J. M., Cantu, E., Flesch, J., Lee, J. C., Lederer, D. J., Lama, V. N., Orens, J., Weinacker, A., Wilkes, D. S., Roe, D., Bhorade, S., Wille, K. M., Ware, L. B., Palmer, S. M., Crespo, M., Demissie, E., Sonnet, J., Shah, A., Kawut, S. M., Bellamy, S. L., Localio, A. R., Christie, J. D.

“…Primary graft dysfunction (PGD) is a major cause of early mortality after lung transplant. We aimed to define objective estimates of PGD risk based on readily…”
Get full text

Plasma Cytokines and Chemokines in Primary Graft Dysfunction Post‐Lung Transplantation by Hoffman, S. A., Wang, L., Shah, C. V., Ahya, V. N., Pochettino, A., Olthoff, K., Shaked, A., Wille, K., Lama, V. N., Milstone, A., Ware, L. B., Orens, J., Weinacker, A., Demissie, E., Bellamy, S., Kawut, S. M., Hancock, W. W., Christie, J. D.

“…Primary graft dysfunction (PGD) after lung transplantation causes significant morbidity and mortality. We aimed to determine the role of cytokines and…”
Get full text

Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post–Lung Transplant Primary Graft Dysfunction Risk by Cantu, E., Suzuki, Y., Diamond, J. M., Ellis, J., Tiwari, J., Beduhn, B., Nellen, J. R., Shah, R., Meyer, N. J., Lederer, D. J., Kawut, S. M., Palmer, S. M., Snyder, L. D., Hartwig, M. G., Lama, V. N., Bhorade, S., Crespo, M., Demissie, E., Wille, K., Orens, J., Shah, P. D., Weinacker, A., Weill, D., Wilkes, D., Roe, D., Ware, L. B., Wang, F., Feng, R., Christie, J. D.

“…The authors previously identified plasma plasminogen activator inhibitor‐1 (PAI‐1) level as a quantitative lung injury biomarker in primary graft dysfunction…”
Get full text

Caring for the orphan's orphan: treatment of patients with portopulmonary hypertension by Kawut, S M

Get full text

New answers raise new questions in pulmonary arterial hypertension by Kawut, S M, Palevsky, H I

Get full text

Extrinsic compression of the left main coronary artery by the pulmonary artery in patients with long-standing pulmonary hypertension by Kawut, Steven M, Silvestry, Frank E, Ferrari, Victor A, DeNofrio, David, Axel, Leon, Loh, Evan, Palevsky, Harold I

“…Left main coronary artery compression by the pulmonary artery may be seen in patients with pulmonary hypertension who are undergoing cardiac catheterization…”
Get full text

Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation by Kawut, Steven M., O’Shea, Mitchell K., Bartels, Matthew N., Wilt, Jessie S., Sonett, Joshua R., Arcasoy, Selim M.

“…Diffuse parenchymal lung disease is associated with a high risk of mortality despite early referral and listing for lung transplantation. We hypothesized that…”
Get full text

Outcomes of extended donor lung recipients after lung transplantation by KAWUT, Steven M, REYENTOVICH, Alexander, WILT, Jessie S, ANZECK, Roberto, LEDERER, David J, O'SHEA, Mitchell K, SONETT, Joshua R, ARCASOY, Selim M

“…Lung transplantation is currently limited by the number of suitable donor organs. Many lung-transplant programs use lungs that do not meet the formal criteria…”
Get full text